Floatz logo

Capecitabine

Internal Radiotherapy

Federation Francophone de Cancerologie DigestiveSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Internal Radiotherapy cohort.

Asset / SponsorPhaseRating
Irinotecan
Federation Francophone de Cancerologie Digestive
Phase 2CCC
Atezolizumab
Federation Francophone de Cancerologie Digestive
Phase 2CCC
(+)-VINCRISTINE
Federation Francophone de Cancerologie Digestive
Phase 2CCC
Eloxatin
Federation Francophone de Cancerologie Digestive
Phase 2CCC

Same molecule, other indications

Capecitabine is also rated in:

Locally Advanced Rectal CancerDormant
BBB
Indicative ·
75 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →
rectal carcinomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →